Ken Griffin Assertio Holdings, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$0.75 - $1.31 $11,175 - $19,519	-14,900 Reduced 47.0%	16,800 $20,000
Q1 2024 May 15, 2024	BUY	$0.79 - $1.14 $13,825 - $19,950	17,500 Added 123.24%	31,700 $30,000
Q4 2023 Feb 14, 2024	SELL	$1.02 - $2.57 $55,794 - $140,579	-54,700 Reduced 79.39%	14,200 $15,000
Q3 2023 Nov 14, 2023	BUY	$2.52 - $5.69 $49,644 - $112,093	19,700 Added 40.04%	68,900 $176,000
Q2 2023 Aug 14, 2023	SELL	$5.0 - $7.66 $9,000 - $13,788	-1,800 Reduced 3.53%	49,200 $266,000
Q1 2023 May 15, 2023	BUY	$3.54 - $6.66 $131,334 - $247,086	37,100 Added 266.91%	51,000 $324,000
Q4 2022 Feb 14, 2023	BUY	$2.11 - $4.3 $29,329 - $59,770	13,900 New	13,900 $59,000

109

37.1M

755K

39.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $44.3M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.